Bosentan, an endothelin receptor antagonist, reduces leucocyte adhesion and inflammation in a murine model of inflammatory bowel disease

被引：0
|
作者：
Christoph Anthoni
Rudolf B. Mennigen
Emile J. M. Rijcken
Mike G. Laukötter
Hans-Ullrich Spiegel
Norbert Senninger
Guido Schürmann
Christian F. Krieglstein
机构：
[1] Westfalian Wilhelm's University,Department of General Surgery
[2] Klinikum Itzehoe,Department of Surgery
[3] LSU Health Science Center,Department of Molecular and Cellular Physiology
来源：
International Journal of Colorectal Disease | 2006年 / 21卷
关键词：
Bosentan; Endothelins; Inflammatory bowel disease; Dextran sodium sulphate; Chronic colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：409 / 418
页数：9
相关论文
共 50 条
  • [11] Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
    Serafim, Karla G. G.
    Navarro, Suelen A.
    Zarpelon, Ana C.
    Pinho-Ribeiro, Felipe A.
    Fattori, Victor
    Cunha, Thiago M.
    Alves-Filho, Jose C.
    Cunha, Fernando Q.
    Casagrande, Rubia
    Verri, Waldiceu A., Jr.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 (11) : 1211 - 1221
  • [12] The opioid antagonist naltrexone improves murine inflammatory bowel disease
    Matters, Gail L.
    Harms, John F.
    McGovern, Christopher
    Fitzpatrick, Leo
    Parikh, Anuj
    Nilo, Nicholas
    Smith, Jill P.
    JOURNAL OF IMMUNOTOXICOLOGY, 2008, 5 (02) : 179 - 187
  • [13] RELATIONSHIP OF INTERLEUKIN-1 RECEPTOR ANTAGONIST TO MUCOSAL INFLAMMATION IN INFLAMMATORY BOWEL-DISEASE
    HYAMS, JS
    FITZGERALD, JE
    WYZGA, N
    MULLER, R
    TREEM, WR
    JUSTINICH, CJ
    KREUTZER, DL
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (04) : 419 - 425
  • [14] Effects of a thromboxane A2 receptor antagonist in an animal model of inflammatory bowel disease
    Taniguchi, T
    Tsukada, H
    Nakamura, H
    Kodama, M
    Fukuda, K
    Tominaga, M
    Seino, Y
    DIGESTION, 1997, 58 (05) : 476 - 478
  • [15] Carbonic Anhydrate I Epitope Peptide Improves Inflammation in a Murine Model of Inflammatory Bowel Disease
    Yagi, Sen
    Abe, Masanori
    Yamashita, Masakatsu
    Mori, Kenichirou
    Yamanishi, Hirofumi
    Arimitsu, Eiji
    Yamamoto, Yasunori
    Takeshita, Eiji
    Ikeda, Yoshio
    Hiasa, Yoichi
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (08) : 1835 - 1846
  • [16] Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease
    Nagar, Jignesh
    Ranade, Sourabh
    Kamath, Vinay
    Singh, Sharad
    Karunanithi, Preethi
    Subramani, Siva
    Venkatesh, Kamala
    Srivastava, Ratika
    Dudhgaonkar, Shailesh
    Vikramadithyan, Reeba Kannimel
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (02) : 328 - 335
  • [17] Miltefosine Suppresses Inflammation in a Mouse Model of Inflammatory Bowel Disease
    Verhaar, Auke P.
    Wildenberg, Manon E.
    te Velde, Anje A.
    Meijer, Sybren L.
    Vos, Anne Christine W.
    Duijvestein, Marjolijn
    Peppelenbosch, Maikel P.
    Hommes, Daniel W.
    van den Brink, Gijs R.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) : 1974 - 1982
  • [18] Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature
    Rutella, Sergio
    Vetrano, Stefania
    Correale, Carmen
    Graziani, Cristina
    Sturm, Andreas
    Spinelli, Antonino
    De Cristofaro, Raimondo
    Repici, Alessandro
    Malesci, Alberto
    Danese, Silvio
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (03) : 625 - 634
  • [19] Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease
    L Vijgen
    M Van Gysel
    A Rector
    I Thoelen
    N Esters
    T Ceelen
    E Vangoidsenhoven
    S Vermeire
    P Rutgeerts
    M Van Ranst
    Genes & Immunity, 2002, 3 : 400 - 406
  • [20] Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease
    Vijgen, L
    Van Gysel, M
    Rector, A
    Thoelen, I
    Esters, N
    Ceelen, T
    Vangoidsenhoven, E
    Vermeire, S
    Rutgeerts, P
    Van Ranst, M
    GENES AND IMMUNITY, 2002, 3 (07) : 400 - 406
12345